JP2021505241A5 - - Google Patents

Download PDF

Info

Publication number
JP2021505241A5
JP2021505241A5 JP2020530311A JP2020530311A JP2021505241A5 JP 2021505241 A5 JP2021505241 A5 JP 2021505241A5 JP 2020530311 A JP2020530311 A JP 2020530311A JP 2020530311 A JP2020530311 A JP 2020530311A JP 2021505241 A5 JP2021505241 A5 JP 2021505241A5
Authority
JP
Japan
Prior art keywords
days
patent document
international
prior
documents cited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020530311A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021505241A (ja
JP7296084B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/059579 external-priority patent/WO2019111132A1/en
Publication of JP2021505241A publication Critical patent/JP2021505241A/ja
Publication of JP2021505241A5 publication Critical patent/JP2021505241A5/ja
Application granted granted Critical
Publication of JP7296084B2 publication Critical patent/JP7296084B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020530311A 2017-12-04 2018-12-03 長時間作用型胃滞留システム Active JP7296084B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762594257P 2017-12-04 2017-12-04
US62/594,257 2017-12-04
US201862681525P 2018-06-06 2018-06-06
US62/681,525 2018-06-06
PCT/IB2018/059579 WO2019111132A1 (en) 2017-12-04 2018-12-03 Long acting gastric residence system

Publications (3)

Publication Number Publication Date
JP2021505241A JP2021505241A (ja) 2021-02-18
JP2021505241A5 true JP2021505241A5 (https=) 2021-11-18
JP7296084B2 JP7296084B2 (ja) 2023-06-22

Family

ID=64902152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020530311A Active JP7296084B2 (ja) 2017-12-04 2018-12-03 長時間作用型胃滞留システム

Country Status (4)

Country Link
US (2) US11547839B2 (https=)
EP (1) EP3720537B1 (https=)
JP (1) JP7296084B2 (https=)
WO (1) WO2019111132A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1258050A1 (zh) 2015-10-23 2019-11-01 Lyndra Therapeutics, Inc. 用於治疗剂缓释的胃驻留系统及其使用方法
EP3386488B1 (en) 2015-12-08 2023-09-06 Lyndra Therapeutics, Inc. Geometric configurations for gastric residence systems
AU2017268840B2 (en) 2016-05-27 2022-02-10 Nortiva Bio, Inc. Materials architecture for gastric residence systems
US11576866B2 (en) 2016-09-30 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
US12023406B2 (en) 2017-06-09 2024-07-02 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
JP7296084B2 (ja) * 2017-12-04 2023-06-22 クレキシオ バイオサイエンシーズ エルティーディー. 長時間作用型胃滞留システム
US11511093B2 (en) 2019-10-11 2022-11-29 Wonkwang University Center for Industry Academy Cooperation Gastroretentive drug delivery device having expandable structure and manufacturing method therefor
US20230270982A1 (en) * 2020-08-30 2023-08-31 Teva Pharmaceutical Industries Ltd. Devices for regio-specific release of carried drug at ileocecal region
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions
CN115518052B (zh) * 2022-09-22 2024-01-02 江苏集萃新型药物制剂技术研究所有限公司 胃滞留制剂及其制备方法
AU2023366929A1 (en) 2022-10-25 2025-05-08 Veradermics, Incorporated Compositions and methods of use for modified release minoxidil

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1318259A (en) 1919-10-07 Resilient wheel
AU449029B2 (en) 1969-08-28 1974-04-17 Commonwealth Scientific And Industrial Research Organisation Device for administration to ruminants
US4220153A (en) 1978-05-08 1980-09-02 Pfizer Inc. Controlled release delivery system
JPS6226215A (ja) 1985-05-10 1987-02-04 メルク エンド カムパニ− インコ−ポレ−テツド 一定に制御した時間内胃中に保持できる薬剤移送装置
US4735804A (en) 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
EP0202159B1 (en) 1985-05-10 1991-07-03 Merck & Co. Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US5002772A (en) 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
JPH03163011A (ja) 1989-08-31 1991-07-15 Yamanouchi Pharmaceut Co Ltd 胃内滞留デバイス
IT1282650B1 (it) 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
IL133196A0 (en) 1999-11-29 2001-03-19 Yissum Res Dev Co Gastroretentive controlled release pharmaceutical dosage forms
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
ES2270982T3 (es) 2000-02-04 2007-04-16 Depomed, Inc. Forma de dosificacion de nucleo y carcasa que se aproxima a una liberacion del farmaco de orden cero.
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
US6723340B2 (en) 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
EP1478345A4 (en) 2002-01-03 2010-11-17 Glaxosmithkline Llc NOVEL PHARMACEUTICAL DOSAGE FORMS AND PROCESS FOR PRODUCTION OF SAID DOSAGE FORMS
GB0214013D0 (en) 2002-06-18 2002-07-31 Euro Celtique Sa Pharmaceutical product
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
IL166183A0 (en) 2005-01-06 2006-01-15 Yissum Res Dev Co Novel diagnostic and imaging techniques of the gi tract
CA2613178A1 (en) 2005-07-15 2007-01-25 Kissei Pharmaceutical Co., Ltd. Sustained release preparation
WO2007072495A2 (en) 2005-11-03 2007-06-28 Sun Pharmaceutical Industries Limited Coated tablets having prolonged gastric retention
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
HUE043365T2 (hu) 2006-01-18 2019-08-28 Intec Pharma Ltd Kiadóberendezés szer orális bevételéhez
WO2007093999A1 (en) 2006-02-15 2007-08-23 Intec Pharma Ltd. A gastro-retentive system for the delivery of macromolecules
WO2007106957A1 (en) 2006-03-21 2007-09-27 Laboratoires Smb S.A. Multiple units controlled-release floating dosage forms
US9579227B2 (en) 2006-03-29 2017-02-28 Eat Little Inc. Ingestible implement for weight control
JPWO2008087882A1 (ja) 2007-01-15 2010-05-06 キッセイ薬品工業株式会社 胃内滞留型レボドパ徐放性製剤
JP2011503048A (ja) 2007-11-08 2011-01-27 グラクソ グループ リミテッド 医薬製剤
KR101601649B1 (ko) 2008-04-18 2016-03-09 인텍 파마 리미티드 카르비도파/레보도파 위체류 약물 전달
EP2133071A1 (en) 2008-06-09 2009-12-16 Université de la Méditerranée Process for making gastroretentive dosage forms
EP2329810A4 (en) 2008-08-18 2012-09-19 Team Academy Of Pharmaceutical Science DRUG DISPENSING SYSTEM WITH MAGNETIC RETENTION, MANUFACTURING PROCESS AND APPLICATION
US20110268666A1 (en) 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
US20110066175A1 (en) 2009-05-07 2011-03-17 Rainbow Medical Ltd. Gastric anchor
US20120321706A1 (en) 2009-10-19 2012-12-20 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
WO2011090724A2 (en) 2009-12-29 2011-07-28 Impax Laboratories, Inc. Gastroretentive solid oral dosage forms with lipid-based low-density excipient
WO2012006963A1 (zh) 2010-07-16 2012-01-19 Zhong Shuguang 在控释制剂中的聚合物增强剂
CN101919803A (zh) 2010-07-16 2010-12-22 钟术光 一种控释制剂
US9941319B2 (en) 2010-10-13 2018-04-10 Monolithic 3D Inc. Semiconductor and optoelectronic methods and devices
EP2635272A1 (en) 2010-11-01 2013-09-11 Intec Pharma Ltd. Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms
US20130072869A1 (en) 2011-09-15 2013-03-21 The Johns Hopkins University Intra-Gastric Timed-Release Drug Delivery System
CA2851765C (en) 2011-10-11 2017-08-15 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
KR101461332B1 (ko) 2013-08-02 2014-11-13 삼성전기주식회사 센서용 검출모듈 및 이를 구비하는 각속도 센서
US9016811B2 (en) 2013-08-05 2015-04-28 Concealment Solutions Inc. Apparatus for concealing household objects
WO2015083171A1 (en) 2013-12-05 2015-06-11 Tulip Medical Ltd. Retentive devices and systems for in-situ release of pharmaceutical active agents
EP3148514B1 (en) 2014-06-02 2024-04-17 Clexio Biosciences Ltd. Expandable gastroretentive dosage form
WO2015191922A1 (en) 2014-06-11 2015-12-17 Massachusetts Institute Of Technology Enteric elastomers
JP2018537201A (ja) 2015-12-02 2018-12-20 クレキシオ バイオサイエンシーズ エルティーディー. 胃保持型投与形態を調整する装置および方法
EP3547974B1 (en) * 2016-12-02 2023-11-15 Clexio Biosciences Ltd. Gastric residence system
JP7296084B2 (ja) * 2017-12-04 2023-06-22 クレキシオ バイオサイエンシーズ エルティーディー. 長時間作用型胃滞留システム

Similar Documents

Publication Publication Date Title
JP2021505241A5 (https=)
JP2019502892A5 (https=)
JP2019536800A5 (https=)
JP2021524958A5 (https=)
JP2019514354A5 (https=)
JP2023021979A5 (https=)
JP2017206702A5 (https=)
JP2017514639A5 (https=)
CN112004801A (zh) 一种c-MET 抑制剂的晶型及其盐型和制备方法
JP2020531120A5 (https=)
JP2020531121A5 (https=)
MX2009012950A (es) ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS.
JP2014509874A5 (https=)
JPWO2019229543A5 (https=)
CY1112511T1 (el) Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline)
EP3005993A3 (en) Gastric bypass system and method
MX2009012949A (es) Anticuerpos humanizados que enlazan a ab (1-42) globulomero y usos de los mismos.
JP2014519662A5 (https=)
JP2020534246A5 (https=)
EP4321165A3 (en) Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents
JP2020512939A5 (https=)
CN110621674A (zh) 一种Valbenazine二对甲苯磺酸盐的晶型及其制备方法和用途
CN106572870A8 (zh) 柔性上下颌骨固定装置
JP2014508098A5 (https=)
JP2017505825A5 (https=)